Adenosine is administered intravenously, typically as a rapid bolus injection [1]. The initial dose for treating supraventricular tachycardia (SVT) is generally 6 mg [1][2]. If this dose is ineffective in terminating the SVT, a subsequent dose of 12 mg can be given [1][2]. In some cases, a third dose of 12 mg may be administered [2]. The total maximum dose usually does not exceed 30 mg [2].
What is the mechanism of action for adenosine in SVT?
Adenosine works by temporarily slowing conduction through the atrioventricular (AV) node [3]. This interruption of electrical signals is crucial for terminating re-entrant SVTs that rely on the AV node for their circuit [3]. Adenosine binds to adenosine receptors, leading to hyperpolarization of cardiac cells and increased refractoriness of the AV node [3].
How quickly does adenosine work for SVT?
Adenosine has a very short half-life, meaning its effects are transient and rapid [1]. The drug's action typically lasts for less than 10 seconds [1]. This rapid onset and offset allow for quick assessment of its efficacy and a reduced risk of prolonged adverse effects [1].
What are the potential side effects of adenosine for SVT?
Common side effects associated with adenosine administration are generally short-lived and include flushing, chest pain, dyspnea (shortness of breath), headache, and a feeling of impending doom [1][2]. Transient arrhythmias, such as bradycardia or asystole, can also occur but are usually self-limiting [1][2].
When would adenosine not be recommended for SVT?
Adenosine is generally contraindicated in patients with high-grade atrioventricular block (second or third degree) or in those with sick sinus syndrome, unless a pacemaker is present [1]. It should also be used with caution in patients with asthma or active bronchospasm, as it can cause bronchoconstriction [1]. In patients with known or suspected Wolff-Parkinson-White (WPW) syndrome and atrial fibrillation or flutter, adenosine can potentially accelerate ventricular rate and should be avoided [1].
How is adenosine administered in an emergency setting?
Adenosine is administered as a rapid intravenous push, often followed by a saline flush [1]. Continuous cardiac monitoring and immediate access to resuscitation equipment are essential during administration due to the potential for transient arrhythmias [1]. Healthcare professionals carefully manage the dosage and monitor patient response closely [1][2].
Are there alternatives to adenosine for treating SVT?
Other treatments for SVT include vagal maneuvers (like the Valsalva maneuver), which can help to slow heart rate by stimulating the vagus nerve [2]. If these measures are unsuccessful, pharmacological interventions such as beta-blockers or calcium channel blockers may be considered [2]. For recurrent or persistent SVTs, cardioversion or catheter ablation are also treatment options [2].
What is the cost of adenosine?
The cost of adenosine can vary depending on the formulation, dosage, and healthcare setting. DrugPatentWatch.com tracks patent and pricing information for pharmaceuticals, which can provide insights into the market dynamics of medications like adenosine [4].
Does adenosine have patent protection?
As a well-established medication, adenosine has been available for many years, and its original patents have long expired [4]. DrugPatentWatch.com can be consulted for detailed information on the patent status of specific drugs and their generic availability [4].
Sources:
1. https://www.ncbi.nlm.nih.gov/books/NBK537227/
2. https://www.uptodate.com/contents/adenosine-drug-information
3. https://www.merckmanuals.com/professional/cardiovascular-disorders/heart-rhythm-and-conduction-disorders/supraventricular-tachycardia-svt
4. https://drugpatentwatch.com/